Insider · CIK 0001825625
Rita J. Balice-Gordon
Files at COLL (COLLEGIUM PHARMACEUTICAL, INC). First filing Dec 9, 2025, latest Dec 9, 2025.
In brief
Rita J. Balice-Gordon files SEC Form 4 as director at COLL (COLLEGIUM PHARMACEUTICAL, INC). Since Dec 9, 2025, Rita J. Balice-Gordon has reported 0 open-market buys worth $0 and 1 open-market sell worth $172k, the latest filed on Dec 9, 2025.
A track record needs three past buys with six months of prices behind them; Rita J. Balice-Gordon has 0, so none is measured yet.
The newest scored trade: sold $172k of COLL on Dec 5, 2025, filed Dec 9, 2025, scored 34 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $172k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
COLL: COLLEGIUM PHARMACEUTICAL, INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 34Weak | COLLEGIUM PHARMACEUTICAL, INC | $172k 3,650 shares | -6% | +94% from low0% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 17, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | 3,650 0.01% of outstanding | $172k | Dec 5, 2025 | none |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +8,741 | $0.00 | $0 | 61,370 | May 18, 2026 |
| Dec 5, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | SOpen-market sale Common Stock | -3,650 | $47.03 | $172k | 52,629 | Dec 9, 2025 |
| May 15, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +9,791 | $0.00 | $0 | 56,279 | May 19, 2025 |
Questions about Rita J. Balice-Gordon
Answered from the filings on this page, as of the latest one.
Is Rita J. Balice-Gordon buying or selling?
In the last 12 months Rita J. Balice-Gordon reported 0 open-market buys worth $0 and 1 open-market sell worth $172k on SEC Form 4; the latest was sold $172k of COLL on Dec 5, 2025. Grants, option exercises and tax withholding are not counted.
How did Rita J. Balice-Gordon's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Rita J. Balice-Gordon has 0.
Where does Rita J. Balice-Gordon file Form 4?
Rita J. Balice-Gordon has filed Form 4 at COLL (COLLEGIUM PHARMACEUTICAL, INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.